Clinical pharmacists have established critical roles in optimizing patient outcomes, but barriers exist to ensure all patients receive this care. Barriers include value tracking and workload metrics, societal impression, and recognizing value in direct and non-direct patient care. These barriers are faced in every discipline of clinical pharmacy. Pharmacists are continually evolving in their practice models to provide the best possible care to patients. The laws around provider status and advanced practice pharmacy models are changing rapidly and often vary from state to state since there is not currently a federal mandate for pharmacist provider status. The recent global pandemic also highlighted the areas where pharmacists can serve to fill in gaps of patient healthcare; many laws were amended or changed to allow pharmacists to provide care during this period and these changing laws will have a lasting impact on the ways pharmacists can impact care. This session will be divided into 3 sections, an introductory session that will highlight current novel practice models that demonstrate the essential role of the pharmacist followed by a pro-con debate about the necessity of provider status or advanced pharmacy practice models to provide impactful patient care.

Faculty

Moderator: Lisa Hayes, BCCCP, BCEMP